Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, November 30, 2009

New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates

New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.